Ridgeback Capital Investments L.P. 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:22 pm Sale |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Ridgeback Capital Investments L.P. | 1,144,979 2.500% |
-869,708 (-43.17%) |
Filing |
| 2020-08-24 6:54 pm Purchase |
2020-08-13 | 13G | Sutro Biopharma, Inc. STRO |
Ridgeback Capital Investments L.P. | 2,014,687 5.300% |
2,014,687 (New Position) |
Filing |